Target intelligence / Profile preview

SEC16 homolog B, endoplasmic reticulum export factor (SEC16B)

Target
SEC16B
Molecular classification
Other, Scaffold protein (COPII vesicle assembly factor), Peripheral membrane protein
01

Overview

SEC16 homolog B, endoplasmic reticulum export factor (SEC16B), is a scaffold protein involved in defining and organizing endoplasmic reticulum exit sites (ERES) for COPII vesicle formation, which mediate selective transport of proteins and lipids from the ER to the Golgi apparatus. SEC16B also has a specialized, non-redundant role in peroxisome biogenesis by regulating the export of biogenesis factors like PEX3 and PEX16 from the ER to peroxisomes. It is distinct from its longer paralog SEC16A and is considered a minor or specialized isoform in mammals. Mutations in SEC16B can result in defective ER export and are associated with certain disease phenotypes including impaired collagen trafficking, osteogenesis imperfecta, cone-rod dystrophy 2, and associations with body mass index. **Notes:** - SEC16B is an essential trafficking protein but not a canonical drug target (such as a receptor, enzyme, or transporter) and is not known to be the direct target of any marketed drug. - No approved drugs, mechanisms of action for drugs, or biomarker applications have been established for SEC16B. - Disruption of SEC16B function can lead to severity in processes that depend on protein or organelle trafficking, but therapeutic targeting/safety concerns are not established due to lack of direct targeting.

Other names
Protein transport protein Sec16BKIAA1928LZTR2RGPRSEC16SRGPR-p117PGPR-p117Sec16SLeucine zipper transcription regulator 2Regucalcin gene promoter region-related protein p117regucalcin gene promotor region related protein
02

Biological functions

Organization of endoplasmic reticulum exit sites (ERES)Secretory cargo trafficking from endoplasmic reticulum (ER) to Golgi apparatusPeroxisome biogenesisRegulation of transport of peroxisomal biogenesis factors (PEX3 and PEX16) from ER to peroxisomes
03

Disease associations

Osteogenesis imperfecta (from loss-of-function/disruption)Cone-rod dystrophy 2 (association)Body mass index quantitative trait (genetic association)
04

Safety considerations

Loss-of-function can disrupt protein trafficking and peroxisome biogenesis, potentially contributing to disease phenotypes such as errors in collagen trafficking or metabolic dysfunctions.

Beyond the preview

Go deeper on SEC16 homolog B, endoplasmic reticulum export factor (SEC16B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEC16 homolog B, endoplasmic reticulum export factor (SEC16B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call